• 3212 Citations
  • 30 h-Index
19962017
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where L. Lakatos is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles
Inflammatory Bowel Diseases Medicine & Life Sciences
Crohn Disease Medicine & Life Sciences
Ulcerative Colitis Medicine & Life Sciences
Hungary Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Mesalamine Medicine & Life Sciences
Population Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2017

  • 3212 Citations
  • 30 h-Index
  • 101 Article
  • 1 Chapter
15 Citations (Scopus)

Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical And Biochemical Markers Play the More Important Role?

Gonczi, L., Vegh, Z., Golovics, P. A., Rutka, M., Gecse, K. B., Bor, R., Farkas, K., Szamosi, T., Bene, L., Gasztonyi, B., Kristóf, T., Lakatos, L., Miheller, P., Palatka, K., Papp, M., Patai, Á., Salamon, Á., Tóth, G. T., Vincze, A., Biro, E. & 5 others, Lovasz, B. D., Kurti, Z., Szepes, Z., Molnár, T. & Lakatos, P., jún. 1 2017, In : Journal of Crohn's & colitis. 11, 6, p. 697-705 9 p.

Research output: Article

Biosimilar Pharmaceuticals
Area Under Curve
Biomarkers
Ulcerative Colitis
Crohn Disease
12 Citations (Scopus)

Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease

Vegh, Z., Kurti, Z., Gonczi, L., Golovics, P. A., Lovasz, B. D., Szita, I., Balogh, M., Pandúr, T., Vavricka, S. R., Rogler, G., Lakatos, L. & Lakatos, P., febr. 11 2016, (Accepted/In press) In : Scandinavian Journal of Gastroenterology. p. 1-7 7 p.

Research output: Article

Inflammatory Bowel Diseases
Anemia
Hospitalization
Ulcerative Colitis
Crohn Disease
100 Citations (Scopus)

Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort

Gecse, K. B., Lovász, B. D., Farkas, K., Banai, J., Bene, L., Gasztonyi, B., Golovics, P. A., Kristóf, T., Lakatos, L., Csontos, Á. A., Juhász, M., Nagy, F., Palatka, K., Papp, M., Patai, Á., Lakner, L., Salamon, Á., Szamosi, T., Szepes, Z., Tóth, G. T. & 4 others, Vincze, A., Szalay, B., Molnár, T. & Lakatos, P., febr. 1 2016, In : Journal of Crohn's & colitis. 10, 2, p. 133-140 8 p.

Research output: Article

Biosimilar Pharmaceuticals
Inflammatory Bowel Diseases
Ulcerative Colitis
Crohn Disease
Safety